Anti-VEGF Maintains Visual Acuity Gains At 1 Year In Patients With Neovascular AMD

Monday, December 13, 2010

Comments

Ocular Surgery News

Pegaptanib as induction-maintenance therapy improved visual acuity and stabilized center point thickness in patients with neovascular age-related macular degeneration, a study found.

Full Story

Retina Products and Equipment »

The glaucoma medications associated with decreased conjunctival goblet cell density are:
1. Prostaglandin analogs
2. Selective beta blockers
3. Non-selective beta blockers
4. Alpha agonists
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Anti-VEGF Maintains Visual Acuity Gains At 1 Year In Patients With Neovascular AMD

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

The glaucoma medications associated with decreased conjunctival goblet cell density are:

AdGlare RMR Ad

Featured Products

CareCloud Central

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us